Skip to main content

Serum Biomarkers and Trafficking Defects in Peripheral Tissues Reflect the Severity of Retinopathy in Three Brothers Affected by Choroideremia

  • Conference paper
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 723))

Abstract

Choroideremia (CHM) is an X-linked form of retinal degeneration, caused by loss of function mutations in the CHM gene that encodes Rab Escort Protein 1 gene (REP1). REP1 is a key regulator of vesicular trafficking, phagosome fusion, and maturation. We investigated the effects of different CHM mutations in monocytes derived from CHM patients. Phagocytosis in monocytes was tracked with a pH-dependent dye conjugated with E. coli, and the rate of degradation of engulfed material was determined using labeled DQTM-Ovalbumin (Molecular Probes, Eugene, OR). Monocytes (CD14+ fraction) from 6 age-matched controls and 3 CHM patients (brothers) with the same mutation in CHM were compared for different aspects of intracellular vesicle transport. The three brothers demonstrated a large degree of variability in trafficking defects and serum levels of PEDF, VEGF, and MCP1 factors, which correlated with the clinical severity of their disease. We demonstrated that peripheral cells from CHM patients have characteristic defects that have not previously been recognized and could be used as alternative models to study the cellular effects of different mutations in the CHM gene and the mechanisms surrounding the progressive retinal degeneration in this condition.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Becq F (2010) Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 70:241–259

    Article  PubMed  CAS  Google Scholar 

  • Gordiyenko NV, Fariss RN, Zhi C et al (2009) Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 51:1143–1150

    Article  PubMed  Google Scholar 

  • Jacobson SG, Cideciyan AV, Sumaroka A et al (2006) Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 47:4113–4120

    Article  PubMed  Google Scholar 

  • MacDonald IM, Sereda C, McTaggart K et al (2004) Choroideremia gene testing. Expert Rev Mol Diagn 4:478–484

    Article  PubMed  CAS  Google Scholar 

  • Moosajee M, Gregory-Evans K, Ellis CD et al (2008) Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet 17:3987–4000

    Article  PubMed  CAS  Google Scholar 

  • Rak A, Pylypenko O, Niculae A et al (2004) Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell 117:749–760

    Article  PubMed  CAS  Google Scholar 

  • Reynolds R, Hartnett ME, Atkinson JP et al (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50:5818–5827

    Article  PubMed  Google Scholar 

  • Rudolph G, Preising M, Kalpadakis P et al (2003) Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet 24:203–214

    Article  PubMed  Google Scholar 

  • Sieving PA, Niffenegger JH, Berson EL (1986) Electroretinographic findings in selected pedigrees with choroideremia. Am J Ophthalmol 101:361–367

    PubMed  CAS  Google Scholar 

  • Strunnikova NV, Barb J, Sergeev YV et al (2009) Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PLoS One 4:e8402

    Article  PubMed  Google Scholar 

  • Tolmachova T, Anders R, Abrink M et al (2006) Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest 116:386–394

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian M. MacDonald .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this paper

Cite this paper

Strunnikova, N., Zein, W.M., Silvin, C., MacDonald, I.M. (2012). Serum Biomarkers and Trafficking Defects in Peripheral Tissues Reflect the Severity of Retinopathy in Three Brothers Affected by Choroideremia. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_49

Download citation

Publish with us

Policies and ethics